Insider · CIK 0001693540

Kamen Robert

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001693540

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-05-03	Jounce Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−61K sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−33.9K sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.8K sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.6K sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.7K sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.7K sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.7K sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2022-06-24	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-06-18	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15.7K sh	—	—	15,700
2020-06-26	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15.7K sh	—	—	15,700
2020-06-26	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+13.6K sh	—	—	13,550
2020-05-06	Neon Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14K sh	—	—	0
2020-05-06	Neon Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.5K sh	—	—	0
2019-06-25	Neon Therapeutics, Inc.Common StockA Award	Director	AAward	+18.5K sh	—	—	18,500
2019-06-12	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15.7K sh	—	—	15,700
2018-06-19	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+13.6K sh	—	—	13,550

Recent filings

Accepted (ET)
May 44
Kamen Robert0001640455-23-000110
SEC(opens sec.gov)
Jun 284
Kamen Robert0001640455-22-000072
SEC(opens sec.gov)
Jun 224
Kamen Robert0001640455-21-000113
SEC(opens sec.gov)
Jul 24/A
Kamen Robert0001640455-20-000088
SEC(opens sec.gov)
Jun 294
Kamen Robert0001640455-20-000072
SEC(opens sec.gov)
May 64
Kamen Robert0001694187-20-000067
SEC(opens sec.gov)
Jun 274
Kamen Robert0001694187-19-000049
SEC(opens sec.gov)
Jun 134
Kamen Robert0001640455-19-000057
SEC(opens sec.gov)
Jun 214
Kamen Robert0001640455-18-000086
SEC(opens sec.gov)

Companies

Address

C/O JOUNCE THERAPEUTICS, INC. 1030 MASSACHUSETTS AVENUE

CAMBRIDGE, MA, 02138